InKaryo Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

InKaryo General Information

Description

Provider of cytogenetic analysis services. The company's experimental protocol and proprietary bioinformatics analysis cover the full genome evenly with specific and accurate digital sequence output thus providing next generation sequencing platforms, sequencing reagents, sequencing applications, genomic diagnostics, and bioinformatics.

Contact Information

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Outcome Management (Healthcare)
Other Industries
Other Healthcare
Other Healthcare Technology Systems
Parent Company
Primary Office
  • NASA Research Park
  • MS 239-24, Building 239 Rm 175
  • Mountain View, CA 94035
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InKaryo Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore InKaryo‘s full profile, request access.

Request a free trial

InKaryo Executive Team (3)

Name Title Board Seat Contact Info
Xitong Li Co-Founder and President
Zhenbin Fan Co-Founder
To view InKaryo’s complete executive team members history, request access »